Medizinische Universität Graz - Research portal

• Go directly to the nagivation.
• Go directly to the content.

• Print view.
• German.
• Contact.
• Data entry.
• Start.
• Open Access.

Circulating Tumor Cells as Biomarker for Minimal Residual Disease in Prostate Cancer

Local Subprojectlead:

Sedlmayr Peter

Duration:

01.10.2013-30.04.2018

Subprogramme

ERA-Net

Type of Research

applied research

Staff

Sedlmayr, Peter, Project Leader

Kroneis, Thomas, Co-worker

Schlögl, Nina, Co-worker

MUG Research Units

Division of Cell Biology, Histology and Embryology

Funded by

FWF, Fonds zur Förderung der Wissenschaftlichen Forschung, Wien, Austria

FWF-Grant-DOI: 10.55776/I1220

Project results published

> Multiplex Gene Expression Profiling of In Vivo Iso... Clin Chem. 2018; 64(2):297-306

> GSTP1 promoter methylation in in-vivo isolated CIC... Advances in Circulating Tumor Cells (ACTC): Liquid Biopsy in Clinical Practice; OCT 4-8, 2017; Ixia, Rhodos, GREECE. 2017.

> Multiplex gene expression profiling of in-vivo iso... Advances in Circulating Tumor Cells (ACTC): Liquid Biopsy in Clinical Practice; OCT 4-8, 2017; Ixia, Rhodos, GREECE. 2017.

> Detection of androgen receptor variant 7 (AR-V7) i... 3rd Advances in Circulating Tumor Cells (ACTC): Liquid Biopsy in Clinical Practice; OCT 4-8; Ixia, Rhodos, GREECE . 2017.